Advanced search×

Endorectal pull-through for Hirschsprung's disease-a multicenter, long-term comparison of results: transanal vs transabdominal approach

J Pediatr Surg 45(6):8 (2010) PMID 20620323

Purpose: Previous studies have reported decreased continence in patients undergoing transanal endorectal pull-through (TERP) for Hirschsprung's disease compared to the older transabdominal approach (TAA). To address this, we examined long-term stooling outcomes in a large, multicenter cohort of patients undergoing either TERP or TAA. Methods: Data were collected from 5 large pediatric institutions. Patient families were surveyed using a stooling score system (0-40, best to worst total score). Inclusion criteria included patients older than 3 years and those who had more than 6 months of recovery after pull-through. Those with total colonic aganglionosis were excluded. Statistical analysis included univariate and multivariate linear regression (significance, P < .05). Results: Two hundred eighty-one patients underwent TERP (192) or TAA (89). Interviews were completed in 149 (104 [52%] TERP vs 45 [52%] TAA). The TAA group had a significantly greater number of daily bowel movements for each respective postoperative year and experienced more early complications (3% vs 1% with >1 complication; P = .061) and late complications (19% vs 4% with >1 complication; P < .001). Although the TAA group had a higher mean enterocolitis score (3.3 +/- 0.4 vs 1.8 +/- 0.2; P < .001), this was not borne out by multivariate regression analysis (P = .276). Parental survey showed that there were no significant differences between procedures in mean total, continence, or stooling pattern scores. Conclusion: Transanal endorectal pull-through was associated with fewer complications and fewer episodes of enterocolitis. In contrast to prior studies, TERP patients did not have a higher rate of incontinence. These results support use of TERP as an excellent surgical approach for children with Hirschsprung's disease.

Copyright © 2010 Elsevier Ltd. All rights reserved.

DOI: 10.1016/j.jpedsurg.2010.02.087
Version: za2963e q8zac q8zb1 q8zc5 q8zd3 q8zef q8zf6 q8zg9

Similar articles you may find interesting…

  1. Cediranib for Metastatic Alveolar Soft Part Sarcoma.

    J Clin Oncol (2013) PMID 23630200

    We also compared gene expression profiles in pre- and post-treatment tumor biopsies and evaluated the effect of cediranib on tumor proliferation and angiogenesis using positron emission tomography and dynamic contrast-enhanced magnetic resonance imaging.ResultsOf 46 patients enrolled, 43 were evalua...
  2. State's Pull-through for Total Colonic Aganglionosis and GI Dismotility.

    Arch Iran Med 16(5):277-80 (2013) PMID 23641741

    We have performed State's pull-through as total colectomy and ileo-proctostomy with long posterior rectal myotomy in TCA  and severe dysmotility disorders. In this retrospective study, 13 patients with TCA were evaluated from1992 through 2012 in two pediatric surgery centers, which...
  3. A phase II single-arm study of induction chemotherapy with cisplatin and gemcitabine followed by concurrent cisplatin and gemcitabine with t...

    Ther Adv Med Oncol 5(3):159-68 (2013) PMID 23634194

    The aim of this study was to evaluate the efficacy and tolerability of the combination of cisplatin-gemcitabine with concurrent thoracic radiotherapy for locally advanced non-small cell lung cancer (LA-NSCLC). This was a phase II, multicenter, open-label, single-arm t...